Combination chemotherapy with mitomycin C and methotrexate is active against metastatic HER2-negative breast cancer even after treatment with anthracycline, taxane, capecitabine, and vinorelbine

BACKGROUND: Combination chemotherapy with mitomycin C and methotrexate (MM) was reported to be effective for 24% of patients with metastatic breast cancer (MBC) who had been treated with anthracycline and taxane. Antimetabolites such as capecitabine and antitubulins such as vinorelbine have been gen...

Descripción completa

Detalles Bibliográficos
Autores principales: Fukuda, Takayo, Tanabe, Masahiko, Kobayashi, Kokoro, Fukada, Ippei, Takahashi, Shunji, Iwase, Takuji, Ito, Yoshinori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514730/
https://www.ncbi.nlm.nih.gov/pubmed/26217553
http://dx.doi.org/10.1186/s40064-015-1159-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514730/
https://www.ncbi.nlm.nih.gov/pubmed/26217553
http://dx.doi.org/10.1186/s40064-015-1159-4

Ejemplares similares